UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study

Bone marrow transplantation (Basingstoke), 2010-11, Vol.45 (11), p.1587-1593

2010

Volltextzugriff (PDF)

The role of allogeneic haematopoietic progenitor cell transplantation in patients with diffuse large B-cell non-Hodgkin lymphomas (DLBCL)

Bone marrow transplantation (Basingstoke), 2013-10, Vol.48 (10), p.1271-1278

2013

Volltextzugriff (PDF)

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.52-58

2011

Volltextzugriff (PDF)

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

Blood, 2001-09, Vol.98 (6), p.1752-1759

2001

Volltextzugriff (PDF)

Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants

Transplant infectious disease, 2016-06, Vol.18 (3), p.405-414

2016

Volltextzugriff (PDF)

P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL‐WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS

HemaSphere, 2022-06, Vol.6, p.446-447

2022

Volltextzugriff (PDF)

S128: A RANDOMISED COMPARISON OF CPX‐351 AND FLAG‐IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL

HemaSphere, 2022-06, Vol.6, p.29-30

2022

Volltextzugriff (PDF)

Dual Glutathione-S-Transferase-θ1 and -μ1 Gene Deletions Determine Imatinib Failure in Chronic Myeloid Leukemia

Clinical pharmacology and therapeutics, 2014-12, Vol.96 (6), p.694-703

2014

Volltextzugriff (PDF)

The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro

Leukemia, 2006-06, Vol.20 (6), p.1073-1079

2006

Volltextzugriff (PDF)

S126: GEMTUZUMAB‐BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. RESULTS FROM THE NCRI AML19 “MIDOTARG” PILOT TRIAL

HemaSphere, 2022-06, Vol.6, p.27-28

2022

Volltextzugriff (PDF)

Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies

Bone marrow transplantation (Basingstoke), 2002-11, Vol.30 (10), p.629-635

2002

Volltextzugriff (PDF)

Peripheral blood stem cell transplantation for POEMS syndrome

Bone marrow transplantation (Basingstoke), 2002-09, Vol.30 (6), p.401-404

2002

Volltextzugriff (PDF)

A case of 'red eye' post allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2007-02, Vol.39 (4), p.241-242

2007

Volltextzugriff (PDF)

Allogeneic stem cell transplantation as treatment for myelofibrosis

Bone marrow transplantation (Basingstoke), 2006-12, Vol.38 (11), p.721-727

2006

Volltextzugriff (PDF)

Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies

Bone marrow transplantation (Basingstoke), 2002-04, Vol.29 (7), p.607-610

2002

Volltextzugriff (PDF)

Melphalan 140mg/m“2” significantly reduces 5 year progression free survival in multiple myeloma patients receiving a peripheral blood autologous stem cell transplant compared with melphalan 200mg/m“2”

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e163-e163

2015

Volltextzugriff (PDF)

Cardiac assessment of patients for haematopoietic stem cell transplantation

Best practice & research. Clinical haematology, 2007-06, Vol.20 (2), p.247-263

2007

Volltextzugriff (PDF)

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

Bone marrow transplantation (Basingstoke), 2022-10, Vol.57 (10), p.1556-1563

2022

Volltextzugriff (PDF)

Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion

Bone marrow transplantation (Basingstoke), 2007-09, Vol.40 (6), p.605-606

2007

Volltextzugriff (PDF)

Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies

Bone marrow transplantation (Basingstoke), 2003-01, Vol.31 (1), p.45-50

2003

Volltextzugriff (PDF)

The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis

International journal of laboratory hematology, 2008-10, Vol.30 (5), p.415-419

2008

Volltextzugriff (PDF)

Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2004-07, Vol.34 (2), p.137-142

2004

Volltextzugriff (PDF)

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial

Blood, 2018-09, Vol.132 (13), p.1452-1454

2018

Volltextzugriff (PDF)

Syndrome 'X' in adult female recipients of bone marrow transplantation for haematological malignancies

Bone marrow transplantation (Basingstoke), 2005-01, Vol.35 (2), p.209-210

2005

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(84)
Berichte
(2)

Sprache

Englisch
(86)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Humans
(60)
Hematology
(51)
Male
(42)
Adult
(40)
Biological And Medical Sciences
(37)
Medical Sciences
(37)
Middle Aged
(37)
Female
(32)
Oncology
(31)
Transplantation
(27)
Immunology
(25)
Stem Cell Transplantation
(22)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(20)
Biophysics
(20)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(20)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(20)
Hematologic Neoplasms - Therapy
(19)
Bone Marrow
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study

The role of allogeneic haematopoietic progenitor cell transplantation in patients with diffuse large B-cell non-Hodgkin lymphomas (DLBCL)

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants

P547: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL‐WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS

S128: A RANDOMISED COMPARISON OF CPX‐351 AND FLAG‐IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL

Dual Glutathione-S-Transferase-θ1 and -μ1 Gene Deletions Determine Imatinib Failure in Chronic Myeloid Leukemia

The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro

S126: GEMTUZUMAB‐BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. RESULTS FROM THE NCRI AML19 “MIDOTARG” PILOT TRIAL

Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies

Peripheral blood stem cell transplantation for POEMS syndrome

A case of 'red eye' post allogeneic stem cell transplantation

Allogeneic stem cell transplantation as treatment for myelofibrosis

Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies

Melphalan 140mg/m“2” significantly reduces 5 year progression free survival in multiple myeloma patients receiving a peripheral blood autologous stem cell transplant compared with melphalan 200mg/m“2”

Cardiac assessment of patients for haematopoietic stem cell transplantation

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion

Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies

The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis

Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial

Syndrome 'X' in adult female recipients of bone marrow transplantation for haematological malignancies

Suchergebnisse filtern